L Portalone

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Lucio Crinò, Giorgio V. Scagliotti, Serafino Ricci et al. · Journal of Clinical Oncology · 1999 · 366 citations

Medicine, Oncology, Pharmacology +17

Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

Riccardo Rosso, Franco Salvati, Andrea Ardizzoni et al. · Cancer · 1990 · 53 citations

Medicine, Oncology, Pharmacology +10

Is delayed chemotherapy-induced emesis well managed in oncological clinical practice?

Alessandra Fabi, Mario Barduagni, Salvatore Di Lauro et al. · Supportive Care in Cancer · 2003 · 51 citations

Medicine, Oncology, Pharmacology +14

Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy‐proven Stage IIIA(N2) nonsmall cell lung carcinoma

Filippo de Marinis, Fabrizio Nelli, Maria Rita Migliorino et al. · Cancer · 2003 · 45 citations

Medicine, Oncology, Pharmacology +14

Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

F Salvati, Guido Rasi, L Portalone et al. · PubMed · 1996 · 45 citations

Medicine, Hematology, Oncology +15